CD8A and neoplasm: These autologous tumor-reactive CD8+ T cells were seen to substantially reduce the survival of the matched PDOs, indicating the potential of this PDO co-culture model in evaluating the responses of immuno-oncology therapies in a personalized manner and in generating patient-specific tumor-killing T cells.